More from Renaissance Capital

Diagnostic testing company Singulex postpones $70 million IPO

By Renaissance Capital,  November 08, 2012, 08:13:47 AM EDT

Singulex, which provides diagnostic testing for cardiovascular disease in a non-acute setting, postponed its IPO on Wednesday. The Alameda, CA-based company was founded in 1997 and booked $38 million in sales for the 12 months ended 6/30/2012. UBS Investment Bank and Piper Jaffray were set to be the joint bookrunners on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks: SGLX



Latest News Video

Police, Protesters Clash in Turkey Border Town
Police, Protesters Clash in Turkey ...
Why Is No One Talking About NOLA Mother's Day Shooting?
Why Is No One Talking About NOLA Mo...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.43 0.07  0.52%
CSCO $ 24.24 0.35  1.48%
MSFT $ 34.87 0.79  2.32%
F $ 15.08 0.44  3.01%
ARUN $ 13.10 4.51  25.61%
SIRI $ 3.50 0.05  1.45%
GE $ 23.46 0.19  0.82%
S $ 7.32 0.04  0.55%